Symptoms, Treatment & Prognosis Guide
Complete guide to dog transmissible venereal tumor (TVT): symptoms, diagnosis, treatment options, costs, and prognosis.
What Is a Dog Transmissible Venereal Tumor?
A dog transmissible venereal tumor (TVT), also known as infectious sarcoma, contagious venereal tumor (CTVT), or Sticker tumor, is a unique type of cancer that spreads between dogs through direct physical contact — most commonly during mating. Unlike other cancers that develop from a dog's own mutated cells, TVT is one of only a few known clonally transmissible cancers in nature. The tumor cells themselves are the infectious agent, transferring from one dog to another as living allografts.
First described by Russian veterinarian M.A. Novinsky in 1876 and later studied extensively by Karl Sticker in 1903, TVT represents an extraordinary biological phenomenon. Research published in the journal ScienceDirect indicates that TVT cells share a common ancestor dating back approximately 6,000 to 11,000 years — making this cancer cell line one of the oldest continuously propagating cell lines known to science.
TVT is most prevalent in tropical and subtropical regions with large free-roaming dog populations, including parts of Central and South America, Africa, Asia, and the Mediterranean. In the United States, cases are relatively uncommon but occur primarily in southern states with warm climates and higher stray dog densities. According to the Merck Veterinary Manual, TVT accounts for a significant percentage of tumors in intact, sexually active dogs in endemic areas.
Recognizing the Symptoms: From Early Warnings to Advanced Signs
Early detection of transmissible venereal tumors dramatically improves treatment outcomes. Symptoms vary depending on tumor location — genital tumors present differently than extragenital (non-genital) tumors, which can appear on the face, nose, mouth, or skin.
| Severity Level | Genital TVT Symptoms | Extragenital TVT Symptoms |
|---|---|---|
| Early Stage (Weeks 1-3) |
|
|
| Progressive Stage (Weeks 3-8) |
|
|
| Advanced Stage (Weeks 8+) |
|
|
Key observation: TVT tumors are characteristically friable (easily crumble and bleed), have a cauliflower-like or multi-nodular appearance, and may appear gray-pink to red. If you notice any unusual growth on your dog's genitalia or face, do not attempt to diagnose at home — schedule a veterinary examination immediately.
Risk Factors: Which Dogs Are Most Vulnerable?
Primary Risk Factors for TVT
- Intact (unspayed/unneutered) status: Sexually active intact dogs face the highest risk due to mating contact
- Free-roaming lifestyle: Dogs with unrestricted outdoor access in endemic regions have greater exposure
- Geographic location: Tropical/subtropical climates with high stray dog populations (Central/South America, Africa, southern Asia, Mediterranean basin)
- Age: Most commonly diagnosed in dogs 2-5 years old (peak reproductive years), though any age is susceptible
- Breed: No specific breed predisposition — risk correlates with behavior and environment rather than genetics
- Immunocompromised status: Dogs with weakened immune systems (from disease, medications, or malnutrition) may develop more aggressive TVT
Less Common Risk Factors
- Extragenital transmission: Dogs that frequently sniff, lick, or investigate other dogs' genital areas can acquire facial or oral TVT
- Multi-dog households: Close physical contact between dogs (grooming, playing) can facilitate spread in rare cases
- Rescue/international adoption: Dogs imported from endemic regions may carry latent or undiagnosed TVT
How Veterinarians Diagnose Transmissible Venereal Tumors
Accurate diagnosis requires veterinary evaluation. Your veterinarian will follow a systematic diagnostic process to differentiate TVT from other tumors, infections, or inflammatory conditions.
Diagnostic Process Overview
- Step 1: Physical Examination & History
Your vet will perform a thorough physical exam, noting tumor size, location, appearance, and consistency. Expect questions about your dog's reproductive status, mating history, contact with stray dogs, and travel history. Estimated cost: $50-$100 (exam fee) - Step 2: Fine Needle Aspiration (FNA) Cytology
A small needle extracts cells from the tumor for microscopic evaluation. TVT cells have a distinctive appearance: round cells with clear, punctate vacuoles in the cytoplasm, often described as a "signet ring" pattern. FNA cytology is the primary diagnostic tool and can often confirm TVT on the same visit. Estimated cost: $80-$200 - Step 3: Biopsy & Histopathology (if needed)
When FNA results are inconclusive, a tissue biopsy provides a definitive diagnosis. The sample is sent to a veterinary pathology lab. Estimated cost: $150-$350 - Step 4: Staging Workup (for advanced cases)
To determine if the tumor has metastasized, your vet may recommend:- Complete blood count (CBC) and serum biochemistry: $80-$200
- Thoracic radiographs (chest X-rays): $150-$300
- Abdominal ultrasound: $250-$500
- Regional lymph node aspiration: $60-$120
- Step 5: PCR Testing (rare, for research or ambiguous cases)
Polymerase chain reaction testing can confirm the characteristic LINE-1/c-myc gene rearrangement unique to TVT cells. Estimated cost: $200-$400
Total diagnostic costs typically range from $200 to $800, depending on case complexity and geographic location. University veterinary teaching hospitals may charge more but offer specialized oncology expertise.
Treatment Options: Chemotherapy, Surgery, and Radiation
The good news about dog transmissible venereal tumors is that they are among the most treatment-responsive cancers in veterinary oncology. Multiple effective options exist, and the choice depends on tumor location, size, staging results, and your dog's overall health.
| Treatment | Success Rate | Duration | Cost Range | Best For |
|---|---|---|---|---|
| Vincristine Chemotherapy (First-line treatment) |
90-95% complete remission | 3-6 weekly injections (occasionally up to 8) | $400-$1,200 total | Most cases; genital and extragenital TVT; gold standard treatment |
| Doxorubicin Chemotherapy (Second-line/rescue) |
80-90% for vincristine-resistant cases | 3-6 treatments every 2-3 weeks | $600-$1,800 total | Vincristine-resistant TVT; metastatic disease |
| Surgical Excision | 50-65% (high recurrence without adjunct chemo) | Single procedure + 2-week recovery | $500-$2,500 | Small, localized tumors; urinary obstruction relief; solitary extragenital masses |
| Radiation Therapy | 85-95% local control | 6-10 fractions over 2-4 weeks | $2,000-$5,000 | Tumors in surgically inaccessible locations; cases non-responsive to chemotherapy |
| Cryosurgery / Electrosurgery | Variable (60-80%) | Single or repeated sessions | $300-$800 | Small, superficial lesions; adjunct to other treatments |
Vincristine Chemotherapy: The Gold Standard
Vincristine sulfate, administered as a brief intravenous injection once weekly, is the treatment of choice for TVT worldwide. According to the Merck Veterinary Manual, most dogs achieve complete tumor regression within 3 to 6 treatments. Side effects are generally mild and may include temporary lethargy, decreased appetite, or mild gastrointestinal upset. Severe bone marrow suppression or neuropathy is uncommon at the dosages used for TVT (typically 0.5-0.7 mg/m² IV).
Your veterinarian will perform a CBC before each injection to monitor white blood cell counts. Treatment continues until complete clinical resolution, usually confirmed by physical exam and, in some cases, follow-up cytology.
When Surgery Is Preferred
Surgical removal is most appropriate when:
- A small, well-defined tumor can be completely excised with clean margins
- A large genital tumor is causing urinary obstruction requiring emergency debulking
- A solitary extragenital mass (e.g., on the nasal planum) is surgically accessible
- The owner cannot commit to multiple chemotherapy visits
However, surgery alone carries a 30-50% recurrence rate because TVT cells often infiltrate surrounding tissues microscopically. Combining surgery with 2-3 post-operative vincristine treatments reduces recurrence to under 10%.
Prognosis and Life Expectancy: What to Expect
Prognosis for dog transmissible venereal tumors is generally excellent when treatment is pursued. Unlike many other canine cancers, TVT rarely metastasizes to distant organs — the metastasis rate is estimated at only 5-10% of cases, and even metastatic disease often responds to chemotherapy.
| Disease Stage | Description | Treatment Response | Expected Outcome |
|---|---|---|---|
| Stage I (Localized, small tumor) |
Single tumor <5 cm, confined to genitalia or skin, no lymph node involvement | Excellent — 95%+ complete remission with vincristine | Normal life expectancy; full recovery expected within 4-6 weeks of starting treatment |
| Stage II (Large local tumor) |
Tumor >5 cm or locally invasive, regional lymph node enlargement possible | Very good — 85-95% complete remission; may require 5-8 treatments | Normal life expectancy with treatment; recovery within 6-10 weeks |
| Stage III (Metastatic disease) |
Metastasis to regional lymph nodes, skin, or distant sites (spleen, liver, lungs, brain — rare) | Good to fair — 70-85% respond to multi-agent chemotherapy | Guarded prognosis; median survival 6-18 months with aggressive treatment; some dogs achieve long-term remission |
| Untreated | No veterinary intervention | Variable — some tumors regress spontaneously over months; others progress aggressively | Poor — progressive tumor growth, secondary infection, organ obstruction; significant suffering; death possible within months |
Natural regression: In approximately 20-25% of cases, TVT tumors may spontaneously regress over 3-9 months as the dog's immune system mounts a response. However, relying on spontaneous regression is not recommended because the tumor can cause significant tissue damage, secondary infections, and metastasis during this period. Treatment should always be pursued under veterinary guidance.
Recurrence: After successful treatment, the recurrence rate is low (under 10%) but not zero. Dogs in endemic areas with continued exposure to infected dogs may acquire a new TVT infection — treatment does not confer lifelong immunity.
Home Care, Management, and Recovery
While your dog undergoes treatment for transmissible venereal tumor, supportive home care plays an important role in recovery and comfort.
During Chemotherapy Treatment
- Monitor appetite and energy levels: Mild lethargy and decreased appetite for 24-48 hours after vincristine injection are normal. Contact your vet if your dog refuses food for more than 48 hours or shows signs of vomiting/diarrhea.
- Keep the tumor site clean: Gently wipe away discharge with a warm, damp cloth. Do not apply over-the-counter creams, ointments, or hydrogen peroxide unless directed by your veterinarian.
- Prevent self-trauma: An Elizabethan collar (cone) may be necessary if your dog licks or bites at the tumor site. Licking can introduce bacteria and worsen secondary infections.
- Strict separation from other dogs: Your dog must have zero physical contact with other intact dogs during treatment to prevent transmission. This includes no mating, no sniffing of genital areas, and separate sleeping areas in multi-dog households.
- Hygiene precautions: While TVT is not known to infect humans, wear disposable gloves when cleaning tumor discharge and wash hands thoroughly afterward. Dispose of soiled materials in sealed bags.
Post-Treatment Monitoring
After completing treatment, schedule follow-up exams at 1 month, 3 months, and 6 months. Watch for any new growths, discharge, or behavioral changes. Dogs in endemic areas should be monitored indefinitely, as reinfection is possible with new exposures.
Lifestyle Adjustments
- Spay or neuter: If your dog is intact, spaying/neutering during or after treatment eliminates mating-related transmission risk and reduces hormonal influences on tumor behavior.
- Supervised outdoor time: Keep your dog on-leash or in a secure, fenced area to prevent contact with stray or unknown dogs.
- Regular veterinary checkups: Semi-annual wellness exams help catch any recurrence early.
Understanding the Full Cost of TVT Treatment
Budgeting for transmissible venereal tumor treatment requires understanding both expected and potential costs. Here is a realistic breakdown based on 2025-2026 veterinary pricing in the United States:
| Service | Low Estimate | High Estimate | Notes |
|---|---|---|---|
| Initial exam & consultation | $50 | $150 | Higher at specialty/emergency clinics |
| FNA cytology | $80 | $200 | In-clinic vs. external lab |
| Biopsy & histopathology | $150 | $350 | If FNA inconclusive |
| CBC & blood chemistry | $80 | $200 | Pre-treatment baseline |
| Staging imaging (X-rays + ultrasound) | $400 | $800 | For advanced/metastatic cases |
| Vincristine chemotherapy (full course) | $400 | $1,200 | 3-6 weekly treatments |
| Surgical excision | $500 | $2,500 | Depends on tumor size and location |
| Radiation therapy (if needed) | $2,000 | $5,000 | Specialty referral required |
| Antibiotics (secondary infection) | $30 | $80 | If infection present |
| Spay/neuter (if not yet performed) | $200 | $600 | Varies by size and clinic |
Typical total cost for straightforward cases: $700-$2,500 (diagnosis + vincristine chemotherapy)
Complex/metastatic cases: $3,000-$8,000+ (staging + multi-modal treatment)
Worst-case scenario (surgery + radiation + extended chemo): $5,000-$10,000+
Many veterinary clinics offer payment plans, and organizations like RedRover and the ASPCA maintain lists of financial assistance resources for pet owners facing unexpected veterinary bills. Pet insurance, if obtained before diagnosis, may cover a portion of treatment costs depending on the policy.
Prevention Strategies
Preventing transmissible venereal tumors is straightforward in principle but requires consistent management:
- Spay or neuter your dog: This single step eliminates mating-related transmission, which accounts for the vast majority of TVT cases. Spaying/neutering also provides numerous other health benefits.
- Supervise outdoor activities: Prevent your dog from roaming freely, especially in areas with stray dog populations. Keep your dog leashed in public spaces.
- Avoid uncontrolled dog-to-dog contact: In endemic regions, limit your dog's close physical interaction with unknown dogs, particularly intact strays.
- Screen breeding dogs: If you are a responsible breeder, visually inspect prospective mates for any genital abnormalities before breeding. Dogs with any suspicious growths should be examined by a veterinarian before mating.
- Quarantine new dogs: When adopting or fostering dogs from endemic regions, have them examined by a veterinarian and observe a 2-4 week quarantine period before introducing them to other dogs.
- Practice good hygiene at dog events: At dog shows, trials, or group activities, prevent dogs from sniffing or licking other dogs' genital areas.
Important note on human transmission: TVT is not considered zoonotic — it does not transmit to humans. However, extremely rare cases of TVT transmission to immunocompromised humans have been documented in medical literature. Standard hygiene practices (handwashing, glove use when handling discharge) are sufficient precautions.
When to See the Vet: Red Flag Symptoms
🚨 Seek Veterinary Care Immediately If You Notice:
- Any growth or mass on your dog's genitalia — regardless of size, color, or whether it appears to cause discomfort
- Persistent bloody or foul-smelling genital discharge lasting more than 24-48 hours (outside of a normal heat cycle)
- Difficulty urinating, straining, or inability to urinate — urinary obstruction is a medical emergency requiring immediate intervention
- Unexplained facial or nasal masses, especially in intact dogs with outdoor access in endemic regions
- Bloody nasal discharge (epistaxis) not attributable to trauma
- Rapidly growing lumps anywhere on the body that have a cauliflower-like, friable, or bleeding appearance
Do not wait to see if the growth resolves on its own. While spontaneous regression can occur, the tumor may cause significant tissue destruction, secondary infection, and metastasis during that time. Early treatment with vincristine is simple, affordable, and highly effective — delaying treatment complicates management and increases costs.
Frequently Asked Questions
Can my dog catch TVT from other species?
No. Transmissible venereal tumors are species-specific to canids. Your dog cannot contract TVT from cats, livestock, or wildlife. The tumor cells have evolved to survive specifically in the canine immune environment.
Is TVT the same as other reproductive cancers in dogs?
No. TVT is fundamentally different from other reproductive tract tumors such as leiomyomas, squamous cell carcinomas, or prostatic tumors. TVT is infectious and transmissible between dogs, while other reproductive cancers arise from the dog's own cells and are not contagious. Accurate diagnosis by a veterinarian is essential because treatment approaches differ dramatically.
Can TVT spread to humans or other pets in the household?
TVT is not considered a risk to humans under normal circumstances. Transmission to other dogs in the household is possible through close physical contact, particularly mating behavior or genital sniffing. Separate affected dogs from other dogs immediately and have all household dogs examined by a veterinarian.
My dog was treated for TVT — can they get it again?
Yes, reinfection is possible. While treatment resolves the current tumor, it does not provide permanent immunity. Dogs that continue to have contact with infected dogs — particularly intact, free-roaming dogs — can acquire new TVT infections. Spaying/neutering and limiting exposure are the best long-term preventive measures.
How quickly does TVT grow?
After initial transmission, there is typically an incubation period of 2-4 weeks before a visible tumor appears. Once established, TVT can grow rapidly — doubling in size every 1-2 weeks in some cases. A small nodule can develop into a large, cauliflower-like mass of 5-10 cm within 4-8 weeks without treatment.
Are there any home remedies for TVT?
No home remedies have been scientifically shown to treat transmissible venereal tumors. Attempting to treat TVT at home delays effective veterinary care and allows the tumor to grow, potentially metastasize, and cause secondary complications. Vincristine chemotherapy is affordable, widely available, and extremely effective — there is no reason to delay professional treatment.
Can puppies get TVT?
While TVT is most common in sexually active adult dogs, puppies can acquire extragenital TVT through contact with an infected mother's genital secretions during nursing or close contact. Puppies with suspicious growths should be evaluated by a veterinarian promptly.
What breeds are prone to transmissible venereal tumors?
TVT does not discriminate by breed. Any dog — purebred or mixed breed — can develop TVT if exposed to infected tumor cells. Risk is driven by behavior and environment (intact status, free-roaming, geographic location) rather than genetic breed predisposition. That said, mixed-breed free-roaming dogs in endemic regions are statistically overrepresented simply because they are more likely to encounter infected dogs.
Bottom line: Dog transmissible venereal tumors are highly treatable when caught early. If you notice any unusual growths on your dog — especially on the genitalia or face — consult your veterinarian promptly. With proper treatment, the vast majority of dogs make a full recovery and go on to live normal, healthy lives. Spaying or neutering your dog remains the single most effective preventive measure against this contagious cancer.
Priya Sutaria
All our authors care for dogs every day — read more of their work on the authors page.
